Stockscreener 앱 받기
1.91
18.63%
0.30
시간 외 거래:
1.97
0.06
+3.14%
전일 마감가:
$1.61
열려 있는:
$1.63
하루 거래량:
2.21M
Relative Volume:
3.92
시가총액:
$118.45M
수익:
-
순이익/손실:
$-73.79M
주가수익비율:
-1.038
EPS:
-1.84
순현금흐름:
$-77.44M
1주 성능:
+49.22%
1개월 성능:
+76.85%
6개월 성능:
+63.25%
1년 성능:
-45.43%
1일 변동 폭
$1.58
$1.98
1주일 범위
$1.27
$1.98
52주 변동 폭
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
명칭
Pyxis Oncology Inc
전화
(617) 221-9059
주소
321 HARRISON AVENUE, BOSTON
PYXS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
1.91 | 99.85M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 개시 | Guggenheim | Buy |
| 2024-11-21 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-11-08 | 개시 | Stephens | Overweight |
| 2024-08-08 | 개시 | Stifel | Buy |
| 2024-05-07 | 재개 | Jefferies | Buy |
| 2024-02-09 | 개시 | BTIG Research | Buy |
| 2024-01-23 | 개시 | Leerink Partners | Outperform |
| 2023-09-05 | 개시 | RBC Capital Mkts | Outperform |
| 2021-11-02 | 개시 | BofA Securities | Neutral |
| 2021-11-02 | 개시 | Credit Suisse | Outperform |
| 2021-11-02 | 개시 | Jefferies | Buy |
모두보기
Pyxis Oncology Inc 주식(PYXS)의 최신 뉴스
Is Pyxis Oncology Inc. stock entering bullish territoryEarnings Growth Summary & AI Driven Stock Movement Reports - Newser
Applying big data sentiment scoring on Pyxis Oncology Inc.July 2025 Volume & Smart Investment Allocation Insights - Newser
Best data tools to analyze Pyxis Oncology Inc. stock2025 Price Targets & Capital Protection Trade Alerts - Newser
Has Pyxis Oncology Inc. formed a bullish divergenceJuly 2025 Rallies & Real-Time Volume Analysis - Newser
A | Is Pyxis Oncology, Inc. backed by strong institutional buyingWeekly Market Report & Consistent Profit Focused Trading Strategies - خودرو بانک
Why is Pyxis Oncology Inc. stock going upMarket Growth Review & Target Return Focused Picks - خودرو بانک
Volatility clustering patterns for Pyxis Oncology Inc.Market Activity Recap & Safe Entry Trade Reports - Newser
Will Pyxis Oncology Inc. benefit from macro trends2025 AllTime Highs & Detailed Earnings Play Alerts - Newser
Applying chart zones and confluence areas to Pyxis Oncology Inc.Market Risk Analysis & Stock Portfolio Risk Management - Newser
How to integrate Pyxis Oncology Inc. into portfolio analysis toolsIndex Update & AI Driven Stock Movement Reports - Newser
Custom strategy builders for tracking Pyxis Oncology Inc.July 2025 Summary & Trade Opportunity Analysis Reports - Newser
Is Pyxis Oncology Inc. still worth holding after the dipPortfolio Update Summary & Weekly High Return Forecasts - Newser
Short interest data insights for Pyxis Oncology Inc.July 2025 Snapshot & Safe Capital Allocation Plans - Newser
Can Pyxis Oncology Inc. lead its sector in growthJuly 2025 Levels & Fast Gain Swing Trade Alerts - خودرو بانک
Guggenheim initiates Buy rating for Pyxis Oncology with a $5 price target. - AInvest
Pyxis Oncology stock initiated with Buy rating at Guggenheim - Investing.com
What’s the recovery path for long term holders of Pyxis Oncology Inc.2025 Dividend Review & Reliable Breakout Stock Forecasts - Newser
How to use Fibonacci retracement on Pyxis Oncology Inc.2025 Dividend Review & Real-Time Volume Analysis Alerts - Newser
Is Pyxis Oncology Inc. building a consolidation baseDividend Hike & Expert Approved Momentum Trade Ideas - Newser
Forecasting Pyxis Oncology Inc. price range with options data2025 Breakouts & Breakdowns & Safe Entry Zone Tips - Newser
Chart based exit strategy for Pyxis Oncology Inc.2025 Major Catalysts & Weekly High Return Opportunities - Newser
Will Pyxis Oncology Inc. stock recover after recent dropWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - Newser
Is it too late to sell Pyxis Oncology Inc.Entry Point & Weekly Breakout Opportunity Watchlist - Newser
What is the long term forecast for Pyxis Oncology Inc. stockJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - خودرو بانک
Can technical indicators confirm Pyxis Oncology Inc.’s reversalMarket Growth Summary & Risk Managed Trade Strategies - Newser
Using data models to predict Pyxis Oncology Inc. stock movementPortfolio Return Report & Low Drawdown Trading Techniques - Newser
Pyxis Oncology Inc (PYXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):